These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26097543)

  • 21. Knockdown of IFI27 inhibits cell proliferation and invasion in oral squamous cell carcinoma.
    Wang H; Qiu X; Lin S; Chen X; Wang T; Liao T
    World J Surg Oncol; 2018 Mar; 16(1):64. PubMed ID: 29580248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quercetin inhibits cell viability, migration and invasion by regulating miR-16/HOXA10 axis in oral cancer.
    Zhao J; Fang Z; Zha Z; Sun Q; Wang H; Sun M; Qiao B
    Eur J Pharmacol; 2019 Mar; 847():11-18. PubMed ID: 30639311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depleting IFIT2 mediates atypical PKC signaling to enhance the migration and metastatic activity of oral squamous cell carcinoma cells.
    Lai KC; Liu CJ; Chang KW; Lee TC
    Oncogene; 2013 Aug; 32(32):3686-97. PubMed ID: 22986528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma.
    Chang KW; Chu TH; Gong NR; Chiang WF; Yang CC; Liu CJ; Wu CH; Lin SC
    Oral Dis; 2013 Sep; 19(6):611-9. PubMed ID: 23231387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.
    Bufalino A; Cervigne NK; de Oliveira CE; Fonseca FP; Rodrigues PC; Macedo CC; Sobral LM; Miguel MC; Lopes MA; Paes Leme AF; Lambert DW; Salo TA; Kowalski LP; Graner E; Coletta RD
    PLoS One; 2015; 10(8):e0136599. PubMed ID: 26317418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
    Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
    Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiRNA-128 and MiRNA-142 Regulate Tumorigenesis and EMT in Oral Squamous Cell Carcinoma Through HOXA10.
    Yao Y; Xu Q; Yan L; Jiao Y; Su Q; Li X; Liu C; Zhao F
    Cancer Manag Res; 2020; 12():9987-9997. PubMed ID: 33116855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased expression of Kallmann syndrome 1 sequence gene (KAL1) contributes to oral squamous cell carcinoma progression and significantly correlates with poorly differentiated grade.
    Liu J; Cao W; Chen W; Xu L; Zhang C
    J Oral Pathol Med; 2015 Feb; 44(2):109-14. PubMed ID: 25060050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Casticin inhibits invasion and proliferation via downregulation of β-catenin and reversion of EMT in oral squamous cell carcinoma.
    Xie Y; Zhong L; Duan D; Li T
    J Oral Pathol Med; 2019 Nov; 48(10):897-905. PubMed ID: 31318467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of Dkk-3 decreases cancer cell migration and invasion independently of the Wnt pathways in oral squamous cell carcinoma‑derived cells.
    Katase N; Lefeuvre M; Tsujigiwa H; Fujii M; Ito S; Tamamura R; Buery RR; Gunduz M; Nagatsuka H
    Oncol Rep; 2013 Apr; 29(4):1349-55. PubMed ID: 23354949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential role of hematopoietic pre-B-cell leukemia transcription factor-interacting protein in oral carcinogenesis.
    Okada S; Irié T; Tanaka J; Yasuhara R; Yamamoto G; Isobe T; Hokazono C; Tachikawa T; Kohno Y; Mishima K
    J Oral Pathol Med; 2015 Feb; 44(2):115-25. PubMed ID: 25060351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma.
    Du Y; Li Y; Lv H; Zhou S; Sun Z; Wang M
    Int J Clin Exp Pathol; 2015; 8(10):12252-9. PubMed ID: 26722410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of miR-155 promotes the proliferation and invasion of oral squamous carcinoma cells by regulating BCL6/cyclin D2.
    Zeng Q; Tao X; Huang F; Wu T; Wang J; Jiang X; Kuang Z; Cheng B
    Int J Mol Med; 2016 May; 37(5):1274-80. PubMed ID: 26986233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness.
    Baba T; Kawaguchi M; Fukushima T; Sato Y; Orikawa H; Yorita K; Tanaka H; Lin CY; Sakoda S; Kataoka H
    J Pathol; 2012 Oct; 228(2):181-92. PubMed ID: 22262311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Myc induced upregulation of long non-coding RNA SNHG16 enhances progression and carcinogenesis in oral squamous cell carcinoma.
    Li S; Zhang S; Chen J
    Cancer Gene Ther; 2019 Nov; 26(11-12):400-410. PubMed ID: 30607006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.
    Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH
    Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma.
    Fang LY; Wong TY; Chiang WF; Chen YL
    J Oral Pathol Med; 2010 Apr; 39(4):342-8. PubMed ID: 20040021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma.
    Liu SL; Zhong SS; Ye DX; Chen WT; Zhang ZY; Deng J
    J Oral Pathol Med; 2013 Nov; 42(10):761-8. PubMed ID: 23651229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells.
    Yamamura M; Noguchi K; Nakano Y; Segawa E; Zushi Y; Takaoka K; Kishimoto H; Hashimoto-Tamaoki T; Urade M
    Int J Oncol; 2013 Mar; 42(3):873-80. PubMed ID: 23292068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of absent in melanoma 2 in oral squamous cell carcinoma contributes to tumor progression.
    Nakamura Y; Nakahata S; Kondo Y; Izumi A; Yamamoto K; Ichikawa T; Tamura T; Noumi K; Yamashita Y; Morishita K
    Biochem Biophys Res Commun; 2019 Jan; 509(1):82-88. PubMed ID: 30587341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.